Charlotta Wallinder
Overview
Explore the profile of Charlotta Wallinder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wallinder C, Skold C, Sundholm S, Guimond M, Yahiaoui S, Lindeberg G, et al.
Medchemcomm
. 2020 Sep;
10(12):2146-2160.
PMID: 32904210
Rigidification of the isobutyl side chain of drug-like AT receptor agonists and antagonists that are structurally related to the first reported selective AT receptor agonist 1 (C21) delivered bioactive indane...
2.
Sallander J, Wallinder C, Hallberg A, Aqvist J, Gutierrez-de-Teran H
Bioorg Med Chem Lett
. 2016 Jan;
26(4):1355-9.
PMID: 26810314
Agonists of the angiotensin II receptor type 2 (AT2), a G-protein coupled receptor, promote tissue protective effects in cardiovascular and renal diseases, while antagonists reduce neuropathic pain. We here report...
3.
Wallinder C, Skold C, Botros M, Guimond M, Hallberg M, Gallo-Payet N, et al.
ACS Med Chem Lett
. 2015 Feb;
6(2):178-82.
PMID: 25699147
Migration of the methylene imidazole side chain in the first reported selective drug-like AT2 receptor agonist C21/M024 (1) delivered the AT2 receptor antagonist C38/M132 (2). We now report that the...
4.
Guimond M, Hallberg M, Gallo-Payet N, Wallinder C
ACS Med Chem Lett
. 2014 Oct;
5(10):1129-32.
PMID: 25313325
Saralasin and sarile, extensively studied over the past 40 years as angiotensin II (Ang II) receptor blockers, induce neurite outgrowth in a NG108-15 cell assay to a similar extent as...
5.
Behrends M, Wallinder C, Wieckowska A, Guimond M, Hallberg A, Gallo-Payet N, et al.
ChemistryOpen
. 2014 May;
3(2):65-75.
PMID: 24808993
A novel series of ligands for the recombinant human AT2 receptor has been synthesized utilizing a fast and efficient palladium-catalyzed procedure for aminocarbonylation as the key reaction. Molybdenum hexacarbonyl [Mo(CO)6]...
6.
Veron J, Joshi A, Wallinder C, Larhed M, Odell L
Bioorg Med Chem Lett
. 2014 Jan;
24(2):476-9.
PMID: 24388688
Sixteen new C-terminally modified analogues of 2, a previously described potent and selective AT2R ligand, were designed, synthesized and evaluated for their affinity to the AT2R receptor. The introduction of...
7.
Wannberg J, Wallinder C, Unlusoy M, Skold C, Larhed M
J Org Chem
. 2013 Mar;
78(8):4184-9.
PMID: 23477584
A convenient procedure for converting aryl alcohols to aryl fluorides via aryl nonafluorobutylsulfonates (ArONf) is presented. Moderate to good one-pot, two-step yields were achieved by this nonaflation and microwave-assisted, palladium-catalyzed...
8.
Guimond M, Wallinder C, Alterman M, Hallberg A, Gallo-Payet N
Eur J Pharmacol
. 2012 Dec;
699(1-3):160-71.
PMID: 23211679
There is increasing evidence that angiotensin II (Ang II), through binding to the type 2 (AT(2)) receptor may have beneficial effects in various physiological and pathological situations. However, specific action...
9.
Shum M, Pinard S, Guimond M, Labbe S, Roberge C, Baillargeon J, et al.
Am J Physiol Endocrinol Metab
. 2012 Nov;
304(2):E197-210.
PMID: 23149621
This study was aimed at establishing whether specific activation of angiotensin II (ANG II) type 2 receptor (AT2R) modulates adipocyte differentiation and function. In primary cultures of subcutaneous (SC) and...
10.
Gallo-Payet N, Guimond M, Bilodeau L, Wallinder C, Alterman M, Hallberg A
Front Endocrinol (Lausanne)
. 2012 Jun;
2:17.
PMID: 22649365
Amyloid-β peptide deposition, abnormal hyperphosphorylation of tau, as well as inflammation and vascular damage, are associated with the development of Alzheimer's disease (AD). Angiotensin II (Ang II) is a peripheral...